Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCT Combined with CD7-CART for CD7+ T-Cell Lymphoma
NCT07106723Phase 2Recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Jun 2025
- Primary completion
- Jan 2029
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CD7-CART in T-cell lymphoma, sponsored by Institute of Hematology and Blood Diseases Hospital. Started Jun 2025; status: recruiting.
02
Drugs
CD7-CART
03
Conditions
T-cell lymphoma
Beyond the preview
Go deeper on NCT07106723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07106723.